Understanding Gynecomastia: Causes, Risk Factors, and When to Seek Care

Gynecomastia is the benign enlargement of male breast tissue. This article explains the causes of gynecomastia, outlines common risk factors, and summarizes typical approaches to evaluation used by clinicians and health organizations. Information here is general and intended for knowledge rather than personalized medical advice.

Causes of gynecomastia: hormonal, drug, and medical factors

Multiple mechanisms can produce the physical finding of gynecomastia. The principal biological pathway involves increased estrogenic activity relative to androgenic activity at the breast tissue. That imbalance can arise through higher estrogen levels, lower testosterone levels, increased sensitivity of breast tissue to estrogen, or external factors that mimic estrogen.

Physiological and developmental causes

Physiological gynecomastia occurs at predictable life stages when hormone balance shifts:

• Neonatal period: Maternal estrogens passed during pregnancy can cause transient breast enlargement in newborns.
• Puberty: Hormonal fluctuations during adolescence commonly cause transient gynecomastia; most cases resolve within months to a few years.
• Older adulthood: Natural decline in testosterone or increased adipose tissue converting androgens to estrogens can contribute to breast enlargement.

Medications, supplements, and substance use

Certain prescriptions and over-the-counter substances are associated with gynecomastia by altering hormone levels or receptor activity. Examples cited in clinical literature and guidance from professional bodies include:

• Medications with estrogenic activity or that reduce androgen production or action (some anti-androgens used for prostate conditions, certain chemotherapy agents).
• Cardiovascular drugs such as some calcium channel blockers and spironolactone in specific contexts.
• Drugs of misuse and recreational substances including anabolic steroids, marijuana, and alcohol when used heavily.
• Herbal or dietary supplements containing plant estrogens or compounds with endocrine activity.

Underlying medical conditions

Several health conditions can change hormone balance or directly affect breast tissue:

• Endocrine disorders: Hypogonadism, hyperthyroidism, and certain pituitary disorders can alter sex hormone levels.
• Liver disease: Cirrhosis and advanced liver disease can reduce estrogen clearance, increasing circulating estrogens.
• Kidney disease and malnutrition: These states can affect hormonal regulation and body composition.
• Hormone-secreting tumors: Rarely, tumors of the testes, adrenal glands, or other tissues that produce estrogens or hCG may be implicated.

Pseudogynecomastia and body composition

Not all apparent breast enlargement represents true glandular proliferation. Excess fatty tissue in the chest due to overweight or obesity is termed pseudogynecomastia. Distinguishing between fatty enlargement and true glandular gynecomastia is part of clinical assessment.

How clinicians evaluate suspected gynecomastia

History and physical examination

Evaluation begins with a detailed history (onset, medications, substance use, systemic symptoms) and focused physical examination to assess the nature of the breast enlargement and look for signs of underlying disease. Professional guidelines from endocrine and family medicine societies recommend targeted testing rather than broad screening in low-risk cases.

Laboratory and imaging tests

When indicated, clinicians may order hormone tests (testosterone, estradiol, luteinizing hormone, thyroid function), liver and kidney function tests, or tumor markers. Ultrasound or mammography may be used to clarify tissue composition. Referral to an endocrinologist or other specialist depends on findings.

For general public information and patient-facing guidance, reputable sources such as the National Health Service (NHS) provide overviews of causes and next steps for evaluation: NHS — Gynecomastia. Clinical practice statements from the Endocrine Society and family medicine associations summarize diagnostic and management considerations for clinicians.

Prevention and management considerations

When the cause is reversible (medication, substance use, or a treatable hormonal imbalance), addressing that factor can reduce or resolve gynecomastia. Weight management can help in cases of pseudogynecomastia. For persistent, bothersome, or suspicious cases, treatment options discussed by clinicians include medical therapies or surgical approaches; decisions should be individualized and guided by qualified clinicians.

When to seek medical evaluation

Seek prompt clinical evaluation when breast enlargement is rapid, unilateral, painful, associated with skin changes, nipple discharge, or systemic symptoms such as unexplained weight loss or signs of hormone-related illness. Routine assessment is reasonable for persistent or distressing enlargement. Health professionals follow established clinical pathways to rule out serious causes and to recommend appropriate care.

What causes of gynecomastia should be considered in adolescent boys?

Pubertal gynecomastia is common due to temporary hormone fluctuations and often resolves without intervention. A clinician will evaluate duration, severity, and any atypical features before recommending observation or further testing.

Can medications cause gynecomastia?

Yes. A range of prescription drugs and supplements has been associated with gynecomastia through effects on hormones or receptors. Reviewing current medications and recent exposures is a routine part of clinical assessment.

How is gynecomastia distinguished from breast cancer or other conditions?

Breast cancer in males is uncommon but may present as a unilateral, fixed mass, often without the soft, concentric glandular enlargement typical of gynecomastia. Imaging and biopsy are used when clinical features raise concern. Clinicians follow best-practice guidelines to triage and investigate suspicious findings.

Is gynecomastia permanent?

Some cases resolve spontaneously (for example, pubertal gynecomastia) or after treating an underlying cause. Longstanding glandular enlargement may become fibrotic and less likely to regress. Treatment options are available and should be discussed with a healthcare professional.

Where to find reliable information and guidance?

Reliable, evidence-based information is provided by national health services and specialty organizations such as the Endocrine Society, the American Academy of Family Physicians, and public health agencies. For patient-oriented information and steps to seek care, consult a local health service or primary care clinician.